1Kass MA. Heuer DK.Higginbotham E, et al. The Ocular Hypertension Treatment Study, a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma[J]. Arch Ophthalmol, 2002, 6(120): 701-713.
3Quigley HA, Broman AT. The number Of people with glaucoma worldwide [J].Br J Ophthalmol,2001, 80: 389-393.
4FuseN,Miyazawa A,TakahashiK,et al.(2010)Mutation Spectrum of CYPlBl Gene for Congenital Glaucoma in the Japanese Population.Jpn. J Ophthalmol,2010,54.1-6.
5Mabuchi F,T&ng S,Keshiwagi K,et al.The OPAl gene polymorphsm is associsted with normal tension srid high tension glsucoma[J].Am J Ophthslmol 2007,143.125-130.
6Suri F, Kalhor R,Zargar SJ,et al.Screening of common CYPlBl mutations in iranian POAG patients using a microarraybased PrASE protocol. Mol Vis[EB/OL].2008,14:56-2349.Available at:http://www.molvis.org/molvis/ v14/a271/. Accessed April 19,2009.
8Bayat B,Yazdani S,Alavi A,et al.Oontributions of MYOC and CYPlBl mutations to JOAG.Mol Vis [EB/OL] 2008,14.17-508 Available at:http://www. molvis.org/molvis/v14/a61/.Accessed April 19,2009.
9Sarfarazi M,Rezaie T.Optineurin in primary open angle glaucoma[J].Ophthalmol Olin North Am,2005,16(4).529-541.
10Whitelaw E,Martin Dl.Retrotransposons as epigenetic mediators of phenotypic variation in mammals[J].Nat Genet,2001,27.361-365.
4Bao Jian Fan Dexter Y. L Leung Dan Yi Wang Stéphane Vincent Raymond Pancy O. S. Tam Dennis S. C. Lam Chi Pui Pang 王婷（译）.青年型开角型青光眼的中国家系的新型Myocilin基因突变[J].美国医学会眼科杂志（中文版）,2006,18(4):256-256. 被引量：5
1Filla MS, Schwinn MK, Sheibani N, et al. Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork ( HTM ) cells by convergence of distinct betal and beta3 integrin pathways. Invest Oph- thalmol Vis Sci, 2009,50:5723-5731.
2Faralli JA,Schwinn MK, Gonzalez JM Jr,et al. Functional properties of fi- bronectin in the trabecular meshwork. Exp Eye Res,2009,88:689-693.
3Peterson JA, Peters DM. Heparin II (Hepll) domain of fibronectin modu- lates rho mediated events in proliferating human trabecular meshwork (HTM) cells via ct41 lntegrin. Invest Ophthalmol Vis Sci,2004,45:E- Abstract 4369.
4Schwinn MK,Gonzalez JM Jr, Gabeh BT, et al. Hepaxin II domain of fi- bronectin mediates contractility through an alpha4betal co-signaling path- way. Exp Cell Res,2010,316:1500-1512.
5Faxalli JA, Peters JM, Newman JR, et al. Effect of heparin II domain of fi- bronectin on actin cytoskeleton and adherens junctions in human trabecu- lax meshwork cells. Invest Ophthalmol V is Sci,2006,47:2924-2931.
